RE: HNWI's24 Aug 2021 10:22
Whatever information they got they liked it, not just 1, 3 different investors now, Sareum certainly can't pull the wool over these guys/girls. So don't let the market pull this from you. If you've ever read a book on the market they talk more and more about the behavioural aspects of trading and basic human actions in times of financial change and scare tactics.
Nothing has changed here, your buying in cheaper than astute investors.
Sareum have been building preclinical data packages on these TYK2 compounds for years, the constant mentioning of tox studies is why I believe this is taking longer, tyk2 have a history of tox, look it up, any big billion pound preclinical deal will need huge amounts data. They are well organised in this respect and that is what we are investing in, to see they attention to detail and technical expertise, read the patent arguments.
It's coming people. Trust the science and we should do well.